Home › Companies › BIO-TECHNE CORP. › 2024-2025
Compiled from SEC Form N-PX filings and BIO-TECHNE CORP.’s Form 8-K, filed 2024-10-30 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore BIO-TECHNE CORP. in the interactive database Compare manager voting policies
These tallies are BIO-TECHNE CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-10-30 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Proposal 1: The shareholders voted to set the number of directors at nine: | 147,416,243 | 587,153 | 106,653 | -- | 0 | Majority: yes |
| Elect Director: Robert V. Baumgartner | 135,629,662 | 7,184,651 | 108,555 | -- | 5,187,181 | Majority: yes |
| Elect Director: Julie L. Bushman | 137,726,895 | 5,090,472 | 105,501 | -- | 5,187,181 | Majority: yes |
| Elect Director: John L. Higgins | 135,544,819 | 7,264,115 | 113,934 | -- | 5,187,181 | Majority: yes |
| Elect Director: Roeland Nusse | 141,573,245 | 1,241,096 | 108,527 | -- | 5,187,181 | Majority: yes |
| Elect Director: Kim Kelderman | 142,088,978 | 730,531 | 103,359 | -- | 5,187,181 | Majority: yes |
| Elect Director: Joseph D. Keegan | 139,194,251 | 3,617,533 | 111,084 | -- | 5,187,181 | Majority: yes |
| Elect Director: Alpna Seth | 137,509,635 | 5,302,948 | 110,285 | -- | 5,187,181 | Majority: yes |
| Elect Director: Rupert Vessey | 140,985,843 | 1,825,907 | 111,118 | -- | 5,187,181 | Majority: yes |
| Elect Director: Judith Klimovsky | 142,641,977 | 176,715 | 104,176 | -- | 5,187,181 | Majority: yes |
| Proposal 3: The shareholders adopted a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement: | 122,860,464 | 19,912,153 | 150,251 | -- | 5,187,181 | Majority: yes |
| Proposal 4: The shareholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2025. | 34,862,262 | 856,480 | 5,701 | -- | 0 | Majority: yes |
Source: BIO-TECHNE CORP., Form 8-K, filed with the SEC on 2024-10-30 — read the filing on EDGAR.
Each item below shows how the 605 asset managers that disclosed a BIO-TECHNE CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BIO-TECHNE CORP.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Proposal 3: The shareholders adopted a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement:”): 122,860,464 for, 19,912,153 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 77% for, 13% against (90% of the company cast a for/against vote).
The 560 asset managers below cast 89% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 19,854,113 | 0 | 0 | 0 | For |
| T. Rowe Price | 17,161,439 | 0 | 0 | 0 | For |
| BlackRock | 10,019,009 | 50,693 | 0 | 0 | For |
| Fidelity | 6,118,233 | 0 | 0 | 0 | For |
| Neuberger Berman | 5,763,339 | 0 | 0 | 0 | For |
| Invesco | 0 | 5,472,105 | 0 | 0 | Against |
| State Street | 5,296,828 | 70,464 | 0 | 0 | For |
| BAMCO INC /NY/ | 4,193,673 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 3,903,149 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 3,759,944 | 0 | 0 | 0 | For |
| DF DENT & CO INC | 3,113,004 | 0 | 0 | 0 | For |
| Charles Schwab | 3,009,664 | 0 | 0 | 0 | For |
| MACKENZIE FINANCIAL CORP | 2,855,203 | 0 | 0 | 0 | For |
| ATLANTA CAPITAL MANAGEMENT CO L L C | 2,797,126 | 34,698 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2,640,342 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 2,331,333 | 0 | 0 | Against |
| Eaton Vance | 2,272,217 | 0 | 0 | 0 | For |
| MFS | 1,963,556 | 0 | 0 | 0 | For |
| Select Equity Group, L.P. | 1,899,072 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,742,764 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,645,294 | 3,151 | 0 | 0 | For |
| MARSHALL WACE, LLP | 0 | 1,623,386 | 0 | 0 | Against |
| AMERIPRISE FINANCIAL INC | 31,595 | 1,400,073 | 0 | 0 | Against |
| Northern Trust | 1,371,803 | 51,095 | 0 | 0 | For |
| Wellington | 1,404,338 | 0 | 0 | 0 | For |
Showing the 25 largest of 560 asset managers. See all 560 in the interactive database.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Proposal 4: The shareholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2025.”): 34,862,262 for, 856,480 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 22% for, 0.6% against (22% of the company cast a for/against vote).
The 142 asset managers below cast 99.9% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,947,404 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,143,744 | 0 | 0 | 0 | For |
| BlackRock | 5,251,245 | 0 | 0 | 0 | For |
| Fidelity | 4,800,720 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 3,759,944 | 0 | 0 | 0 | For |
| Invesco | 2,634,533 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,302,872 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,253,237 | 0 | 0 | 0 | For |
| Eaton Vance | 2,186,217 | 0 | 0 | 0 | For |
| MFS | 1,963,556 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,742,764 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,648,445 | 0 | 0 | 0 | For |
| State Street | 1,581,461 | 32 | 0 | 0 | For |
| Charles Schwab | 1,489,965 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 1,261,755 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 872,411 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 861,643 | 0 | 0 | 0 | For |
| Ownership Capital B.V. | 855,881 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 807,376 | 0 | 0 | 0 | For |
| Hartford | 759,423 | 0 | 0 | 0 | For |
| Royce | 629,793 | 0 | 0 | 0 | For |
| BNY Mellon | 584,210 | 0 | 0 | 0 | For |
| ALGER FUNDS | 569,146 | 0 | 0 | 0 | For |
| Lincoln Financial | 554,647 | 0 | 0 | 0 | For |
| Dimensional | 547,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Alpna Seth”): 137,509,635 for, 5,302,948 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 87% for, 3% against (90% of the company cast a for/against vote).
The 140 asset managers below cast 97% of the shares they voted on this item FOR (74,897,980 for, 1,921,677 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,947,404 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,143,744 | 0 | 0 | 0 | For |
| BlackRock | 5,249,722 | 1,523 | 0 | 0 | For |
| Fidelity | 4,800,720 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 3,759,944 | 0 | 0 | 0 | For |
| Invesco | 2,634,533 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,302,872 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,253,237 | 0 | 0 | 0 | For |
| Eaton Vance | 2,186,217 | 0 | 0 | 0 | For |
| MFS | 1,963,556 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,742,764 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,648,445 | 0 | 0 | 0 | For |
| State Street | 1,581,362 | 131 | 0 | 0 | For |
| Charles Schwab | 1,489,965 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 1,261,755 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 872,411 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 861,643 | 0 | 0 | 0 | For |
| Ownership Capital B.V. | 855,881 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 807,376 | 0 | 0 | 0 | For |
| Hartford | 759,423 | 0 | 0 | 0 | For |
| Royce | 629,793 | 0 | 0 | 0 | For |
| BNY Mellon | 66,843 | 517,367 | 0 | 0 | Against |
| ALGER FUNDS | 0 | 569,146 | 0 | 0 | Against |
| Lincoln Financial | 545,573 | 9,074 | 0 | 0 | For |
| Dimensional | 0 | 547,037 | 0 | 0 | Against |
Showing the 25 largest of 140 asset managers. See all 140 in the interactive database.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Elect Director: John L. Higgins”): 135,544,819 for, 7,264,115 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 85% for, 5% against (90% of the company cast a for/against vote).
The 140 asset managers below cast 99% of the shares they voted on this item FOR (75,998,249 for, 821,408 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,947,404 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,143,744 | 0 | 0 | 0 | For |
| BlackRock | 5,249,722 | 1,523 | 0 | 0 | For |
| Fidelity | 4,800,720 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 3,759,944 | 0 | 0 | 0 | For |
| Invesco | 2,634,533 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,302,872 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,253,237 | 0 | 0 | 0 | For |
| Eaton Vance | 2,186,217 | 0 | 0 | 0 | For |
| MFS | 1,963,556 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,742,764 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,648,445 | 0 | 0 | 0 | For |
| State Street | 1,581,329 | 164 | 0 | 0 | For |
| Charles Schwab | 1,489,965 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 1,261,755 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 872,411 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 861,643 | 0 | 0 | 0 | For |
| Ownership Capital B.V. | 855,881 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 707,203 | 100,173 | 0 | 0 | For |
| Hartford | 759,423 | 0 | 0 | 0 | For |
| Royce | 629,793 | 0 | 0 | 0 | For |
| BNY Mellon | 584,210 | 0 | 0 | 0 | For |
| ALGER FUNDS | 0 | 569,146 | 0 | 0 | Against |
| Lincoln Financial | 554,647 | 0 | 0 | 0 | For |
| Dimensional | 547,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 140 asset managers. See all 140 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Joseph D. Keegan”): 139,194,251 for, 3,617,533 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 88% for, 2% against (90% of the company cast a for/against vote).
The 140 asset managers below cast 99.0% of the shares they voted on this item FOR (76,121,344 for, 698,313 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,947,404 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,143,744 | 0 | 0 | 0 | For |
| BlackRock | 5,249,722 | 1,523 | 0 | 0 | For |
| Fidelity | 4,800,720 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 3,759,944 | 0 | 0 | 0 | For |
| Invesco | 2,634,533 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,302,872 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,253,237 | 0 | 0 | 0 | For |
| Eaton Vance | 2,186,217 | 0 | 0 | 0 | For |
| MFS | 1,963,556 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,742,764 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,648,445 | 0 | 0 | 0 | For |
| State Street | 1,581,362 | 131 | 0 | 0 | For |
| Charles Schwab | 1,489,965 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 1,261,755 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 872,411 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 861,643 | 0 | 0 | 0 | For |
| Ownership Capital B.V. | 855,881 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 807,376 | 0 | 0 | 0 | For |
| Hartford | 759,423 | 0 | 0 | 0 | For |
| Royce | 629,793 | 0 | 0 | 0 | For |
| BNY Mellon | 584,210 | 0 | 0 | 0 | For |
| ALGER FUNDS | 0 | 569,146 | 0 | 0 | Against |
| Lincoln Financial | 554,647 | 0 | 0 | 0 | For |
| Dimensional | 547,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 140 asset managers. See all 140 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Judith Klimovsky”): 142,641,977 for, 176,715 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 90% for, 0.2% against (90% of the company cast a for/against vote).
The 140 asset managers below cast 99.9% of the shares they voted on this item FOR (76,819,244 for, 413 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,947,404 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,143,744 | 0 | 0 | 0 | For |
| BlackRock | 5,251,245 | 0 | 0 | 0 | For |
| Fidelity | 4,800,720 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 3,759,944 | 0 | 0 | 0 | For |
| Invesco | 2,634,533 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,302,872 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,253,237 | 0 | 0 | 0 | For |
| Eaton Vance | 2,186,217 | 0 | 0 | 0 | For |
| MFS | 1,963,556 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,742,764 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,648,445 | 0 | 0 | 0 | For |
| State Street | 1,581,493 | 0 | 0 | 0 | For |
| Charles Schwab | 1,489,965 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 1,261,755 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 872,411 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 861,643 | 0 | 0 | 0 | For |
| Ownership Capital B.V. | 855,881 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 807,376 | 0 | 0 | 0 | For |
| Hartford | 759,423 | 0 | 0 | 0 | For |
| Royce | 629,793 | 0 | 0 | 0 | For |
| BNY Mellon | 584,210 | 0 | 0 | 0 | For |
| ALGER FUNDS | 569,146 | 0 | 0 | 0 | For |
| Lincoln Financial | 554,647 | 0 | 0 | 0 | For |
| Dimensional | 547,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 140 asset managers. See all 140 in the interactive database.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Julie L. Bushman”): 137,726,895 for, 5,090,472 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 87% for, 3% against (90% of the company cast a for/against vote).
The 140 asset managers below cast 99% of the shares they voted on this item FOR (75,944,300 for, 875,357 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,947,404 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,143,744 | 0 | 0 | 0 | For |
| BlackRock | 5,250,727 | 518 | 0 | 0 | For |
| Fidelity | 4,800,720 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 3,759,944 | 0 | 0 | 0 | For |
| Invesco | 2,634,533 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,302,872 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,253,237 | 0 | 0 | 0 | For |
| Eaton Vance | 2,186,217 | 0 | 0 | 0 | For |
| MFS | 1,963,556 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,742,764 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,648,445 | 0 | 0 | 0 | For |
| State Street | 1,581,453 | 40 | 0 | 0 | For |
| Charles Schwab | 1,489,965 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 1,261,755 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 872,411 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 861,643 | 0 | 0 | 0 | For |
| Ownership Capital B.V. | 0 | 855,881 | 0 | 0 | Against |
| Bridge Builder Trust | 807,376 | 0 | 0 | 0 | For |
| Hartford | 759,423 | 0 | 0 | 0 | For |
| Royce | 629,793 | 0 | 0 | 0 | For |
| BNY Mellon | 584,210 | 0 | 0 | 0 | For |
| ALGER FUNDS | 569,146 | 0 | 0 | 0 | For |
| Lincoln Financial | 554,647 | 0 | 0 | 0 | For |
| Dimensional | 547,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 140 asset managers. See all 140 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Kim Kelderman”): 142,088,978 for, 730,531 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 89% for, 0.5% against (90% of the company cast a for/against vote).
The 140 asset managers below cast 99.9% of the shares they voted on this item FOR (76,819,237 for, 420 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,947,404 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,143,744 | 0 | 0 | 0 | For |
| BlackRock | 5,251,245 | 0 | 0 | 0 | For |
| Fidelity | 4,800,720 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 3,759,944 | 0 | 0 | 0 | For |
| Invesco | 2,634,533 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,302,872 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,253,237 | 0 | 0 | 0 | For |
| Eaton Vance | 2,186,217 | 0 | 0 | 0 | For |
| MFS | 1,963,556 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,742,764 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,648,445 | 0 | 0 | 0 | For |
| State Street | 1,581,486 | 7 | 0 | 0 | For |
| Charles Schwab | 1,489,965 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 1,261,755 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 872,411 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 861,643 | 0 | 0 | 0 | For |
| Ownership Capital B.V. | 855,881 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 807,376 | 0 | 0 | 0 | For |
| Hartford | 759,423 | 0 | 0 | 0 | For |
| Royce | 629,793 | 0 | 0 | 0 | For |
| BNY Mellon | 584,210 | 0 | 0 | 0 | For |
| ALGER FUNDS | 569,146 | 0 | 0 | 0 | For |
| Lincoln Financial | 554,647 | 0 | 0 | 0 | For |
| Dimensional | 547,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 140 asset managers. See all 140 in the interactive database.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Robert V. Baumgartner”): 135,629,662 for, 7,184,651 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 85% for, 5% against (90% of the company cast a for/against vote).
The 140 asset managers below cast 99.8% of the shares they voted on this item FOR (76,709,809 for, 109,848 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,947,404 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,143,744 | 0 | 0 | 0 | For |
| BlackRock | 5,250,169 | 1,076 | 0 | 0 | For |
| Fidelity | 4,800,720 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 3,759,944 | 0 | 0 | 0 | For |
| Invesco | 2,634,533 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,302,872 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,253,237 | 0 | 0 | 0 | For |
| Eaton Vance | 2,186,217 | 0 | 0 | 0 | For |
| MFS | 1,963,556 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,742,764 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,648,445 | 0 | 0 | 0 | For |
| State Street | 1,581,420 | 73 | 0 | 0 | For |
| Charles Schwab | 1,489,965 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 1,261,755 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 872,411 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 861,643 | 0 | 0 | 0 | For |
| Ownership Capital B.V. | 855,881 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 707,203 | 100,173 | 0 | 0 | For |
| Hartford | 759,423 | 0 | 0 | 0 | For |
| Royce | 629,793 | 0 | 0 | 0 | For |
| BNY Mellon | 584,210 | 0 | 0 | 0 | For |
| ALGER FUNDS | 569,146 | 0 | 0 | 0 | For |
| Lincoln Financial | 554,647 | 0 | 0 | 0 | For |
| Dimensional | 547,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 140 asset managers. See all 140 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Roeland Nusse”): 141,573,245 for, 1,241,096 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 89% for, 0.8% against (90% of the company cast a for/against vote).
The 140 asset managers below cast 99.9% of the shares they voted on this item FOR (76,818,580 for, 1,077 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,947,404 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,143,744 | 0 | 0 | 0 | For |
| BlackRock | 5,250,727 | 518 | 0 | 0 | For |
| Fidelity | 4,800,720 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 3,759,944 | 0 | 0 | 0 | For |
| Invesco | 2,634,533 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,302,872 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,253,237 | 0 | 0 | 0 | For |
| Eaton Vance | 2,186,217 | 0 | 0 | 0 | For |
| MFS | 1,963,556 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,742,764 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,648,445 | 0 | 0 | 0 | For |
| State Street | 1,581,445 | 48 | 0 | 0 | For |
| Charles Schwab | 1,489,965 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 1,261,755 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 872,411 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 861,643 | 0 | 0 | 0 | For |
| Ownership Capital B.V. | 855,881 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 807,376 | 0 | 0 | 0 | For |
| Hartford | 759,423 | 0 | 0 | 0 | For |
| Royce | 629,793 | 0 | 0 | 0 | For |
| BNY Mellon | 584,210 | 0 | 0 | 0 | For |
| ALGER FUNDS | 569,146 | 0 | 0 | 0 | For |
| Lincoln Financial | 554,647 | 0 | 0 | 0 | For |
| Dimensional | 547,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 140 asset managers. See all 140 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Rupert Vessey”): 140,985,843 for, 1,825,907 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 89% for, 1% against (90% of the company cast a for/against vote).
The 140 asset managers below cast 99.9% of the shares they voted on this item FOR (76,818,507 for, 1,150 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,947,404 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,143,744 | 0 | 0 | 0 | For |
| BlackRock | 5,250,727 | 518 | 0 | 0 | For |
| Fidelity | 4,800,720 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 3,759,944 | 0 | 0 | 0 | For |
| Invesco | 2,634,533 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,302,872 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,253,237 | 0 | 0 | 0 | For |
| Eaton Vance | 2,186,217 | 0 | 0 | 0 | For |
| MFS | 1,963,556 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,742,764 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,648,445 | 0 | 0 | 0 | For |
| State Street | 1,581,453 | 40 | 0 | 0 | For |
| Charles Schwab | 1,489,965 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 1,261,755 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 872,411 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 861,643 | 0 | 0 | 0 | For |
| Ownership Capital B.V. | 855,881 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 807,376 | 0 | 0 | 0 | For |
| Hartford | 759,423 | 0 | 0 | 0 | For |
| Royce | 629,793 | 0 | 0 | 0 | For |
| BNY Mellon | 584,210 | 0 | 0 | 0 | For |
| ALGER FUNDS | 569,146 | 0 | 0 | 0 | For |
| Lincoln Financial | 554,647 | 0 | 0 | 0 | For |
| Dimensional | 547,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 140 asset managers. See all 140 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Proposal 1: The shareholders voted to set the number of directors at nine:”): 147,416,243 for, 587,153 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 93% for, 0.4% against (93% of the company cast a for/against vote).
The 138 asset managers below cast 99.9% of the shares they voted on this item FOR (76,804,618 for, 413 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,947,404 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,143,744 | 0 | 0 | 0 | For |
| BlackRock | 5,251,245 | 0 | 0 | 0 | For |
| Fidelity | 4,800,720 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 3,759,944 | 0 | 0 | 0 | For |
| Invesco | 2,634,533 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,302,872 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,253,237 | 0 | 0 | 0 | For |
| Eaton Vance | 2,186,217 | 0 | 0 | 0 | For |
| MFS | 1,963,556 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,742,764 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,648,445 | 0 | 0 | 0 | For |
| State Street | 1,581,493 | 0 | 0 | 0 | For |
| Charles Schwab | 1,489,965 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 1,261,755 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 872,411 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 861,643 | 0 | 0 | 0 | For |
| Ownership Capital B.V. | 855,881 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 807,376 | 0 | 0 | 0 | For |
| Hartford | 759,423 | 0 | 0 | 0 | For |
| Royce | 629,793 | 0 | 0 | 0 | For |
| BNY Mellon | 584,210 | 0 | 0 | 0 | For |
| ALGER FUNDS | 569,146 | 0 | 0 | 0 | For |
| Lincoln Financial | 554,647 | 0 | 0 | 0 | For |
| Dimensional | 547,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 138 asset managers. See all 138 in the interactive database.
86% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Proposal 3: The shareholders adopted a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement:”): 122,860,464 for, 19,912,153 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 77% for, 13% against (90% of the company cast a for/against vote).
The 20 asset managers below cast 52.0% of the shares they voted on this item FOR (1,109,437 for, 1,025,951 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Ownership Capital B.V. | 0 | 855,881 | 0 | 0 | Against |
| JPMorgan | 379,703 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 286,312 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 271,017 | 0 | 0 | 0 | For |
| APG Asset Management US Inc. | 102,131 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 88,831 | 0 | 0 | Against |
| TD ASSET MANAGEMENT INC | 41,241 | 0 | 0 | 0 | For |
| Coyle Financial Counsel LLC | 20,799 | 0 | 0 | 0 | For |
| Empower | 0 | 18,326 | 0 | 0 | Against |
| Cardano Risk Management B.V. | 0 | 12,677 | 0 | 0 | Against |
| NORDEA INVESTMENT MANAGEMENT AB | 0 | 11,791 | 0 | 0 | Against |
| Union Investment Institutional GmbH | 0 | 10,000 | 0 | 0 | Against |
| Union Investment Privatfonds GmbH | 0 | 9,925 | 0 | 0 | Against |
| BEACON INVESTMENT ADVISORY SERVICES, INC. | 6,257 | 0 | 0 | 0 | For |
| OSSIAM | 0 | 5,463 | 0 | 0 | Against |
| Desjardins Global Asset Management Inc. | 0 | 5,274 | 0 | 0 | Against |
| HC CAPITAL TRUST | 0 | 4,564 | 0 | 0 | Against |
| GROUPAMA ASSET MANAGMENT | 0 | 3,219 | 0 | 0 | Against |
| Virtus | 1,949 | 0 | 0 | 0 | For |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma | 28 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Proposal 3: The shareholders adopted a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement:”): 122,860,464 for, 19,912,153 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 77% for, 13% against (90% of the company cast a for/against vote).
The 8 asset managers below cast 78% of the shares they voted on this item FOR (139,912 for, 39,680 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Summit Creek Advisors LLC | 66,684 | 0 | 0 | 0 | For |
| HAHN CAPITAL MANAGEMENT LLC | 44,209 | 0 | 0 | 0 | For |
| WILLIAMSBURG INVESTMENT TRUST | 0 | 38,000 | 0 | 0 | Against |
| PRENTISS SMITH & CO INC | 19,060 | 0 | 0 | 0 | For |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 0 | 0 | 0 | 0 | Not Voted |
| Simplify Exchange Traded Funds | 7,462 | 0 | 0 | 0 | For |
| Claret Asset Management Corp | 2,497 | 0 | 0 | 0 | For |
| COURIER CAPITAL LLC | 0 | 1,680 | 0 | 0 | Against |
Combines 2 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Proposal 3: The shareholders adopted a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement:”): 122,860,464 for, 19,912,153 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 77% for, 13% against (90% of the company cast a for/against vote).
The 1 asset managers below cast 100% of the shares they voted on this item FOR (228,589 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| CRM Mutual Fund Trust | 228,589 | 0 | 0 | 0 | For |
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (14,626 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Cardano Risk Management B.V. | 12,677 | 0 | 0 | 0 | For |
| Virtus | 1,949 | 0 | 0 | 0 | For |
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WILLIAMSBURG INVESTMENT TRUST | 38,000 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 7,462 | 0 | 0 | 0 | For |
99.6% Majority: yes · of votes cast
BIO-TECHNE CORP.’s own tally for this item (“Proposal 1: The shareholders voted to set the number of directors at nine:”): 147,416,243 for, 587,153 against, per its Form 8-K filed 2024-10-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 93% for, 0.4% against (93% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (45,462 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WILLIAMSBURG INVESTMENT TRUST | 38,000 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 7,462 | 0 | 0 | 0 | For |
Ranked by the number of BIO-TECHNE CORP. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 158,878,127 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 12.50% |
| 2 | T. Rowe Price | 10.80% |
| 3 | BlackRock | 6.34% |
| 4 | Fidelity | 3.85% |
| 5 | Neuberger Berman | 3.63% |
| 6 | Invesco | 3.44% |
| 7 | State Street | 3.38% |
| 8 | BAMCO INC /NY/ | 2.64% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.46% |
| 10 | BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 2.37% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Vanguard Group | 11.66% | 13F |
| Malvern, PA | 11.58% | DEF14A |
| BlackRock | 8.65% | 13F |
| New York, NY | 7.53% | DEF14A |
| T. Rowe Price | 7.16% | 13F |
| Baltimore, MD | 6.40% | DEF14A |
| FMR LLC | 4.95% | 13G |
| State Street | 4.11% | 13F |
| Morgan Stanley | 3.60% | 13F |
| Invesco | 2.64% | 13F |
Percentages above are of 158,878,127 shares outstanding, as reported by BIO-TECHNE CORP. on its Form 10-Q dated 2024-09-30 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BIO-TECHNE CORP.’s 10-Q dated 2024-09-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At BIO-TECHNE CORP.'s shareholder meeting held 2024-10-24, in the 2024-2025 proxy season, 605 asset managers reported how they voted in their SEC Form N-PX filings, covering 8,193 separate fund positions. Their filings are grouped here into 18 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approve, on an advisory basis, the compensation of our executive officers. — FOR was 86% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: BIO-TECHNE CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-10-30.
BIO-TECHNE CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.